BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7243422)

  • 1. Can the physician diagnose hyperactivity in the office?
    Sleator EK; Ullmann RK
    Pediatrics; 1981 Jan; 67(1):13-7. PubMed ID: 7243422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the hyperactive child in your office: is it ADHD?
    Johnson TM
    Am Fam Physician; 1997 Jul; 56(1):155-60, 168-70. PubMed ID: 9225672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-deficit hyperactivity disorder. Getting control of impulsive behavior.
    Leung AK; Robson WL; Fagan JE; Lim SH
    Postgrad Med; 1994 Feb; 95(2):153-60. PubMed ID: 8309858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperactivity (attention-deficit disorder).
    Martin CA; Welsh RJ; McKay SE; Bareuther CM
    J Fam Pract; 1984 Sep; 19(3):367-9, 372-3, 376-7 passim. PubMed ID: 6381638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and management of attention-deficit hyperactivity disorder.
    Taylor MA
    Am Fam Physician; 1997 Feb; 55(3):887-94, 897, 901 passim. PubMed ID: 9048509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder: assessment, diagnosis, and management.
    Searight HR; Nahlik JE; Campbell DC
    J Fam Pract; 1995 Mar; 40(3):270-9. PubMed ID: 7876785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-regulation of slow cortical potentials: a new treatment for children with attention-deficit/hyperactivity disorder.
    Strehl U; Leins U; Goth G; Klinger C; Hinterberger T; Birbaumer N
    Pediatrics; 2006 Nov; 118(5):e1530-40. PubMed ID: 17060480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of attention deficit-hyperactivity disorder in children with nonmonosymptomatic nocturnal enuresis: a 4-year followup study.
    Baeyens D; Roeyers H; Van Erdeghem S; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2616-20. PubMed ID: 17945295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease.
    Shillingford AJ; Glanzman MM; Ittenbach RF; Clancy RR; Gaynor JW; Wernovsky G
    Pediatrics; 2008 Apr; 121(4):e759-67. PubMed ID: 18381503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parent ratings of school behaviour in children at risk of attention deficit/hyperactivity disorder.
    Sayal K; Taylor E
    Acta Psychiatr Scand; 2005 Jun; 111(6):460-5. PubMed ID: 15877713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
    Biederman J; Gao H; Rogers AK; Spencer TJ
    Biol Psychiatry; 2006 Nov; 60(10):1106-10. PubMed ID: 16806096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.
    Monastra VJ
    Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prescription of stimulants for hyperactive children: a pilot study of incentives and constraints on parents, teachers and physicians].
    Doré C; Cohen D
    Sante Ment Que; 1997; 22(1):216-38. PubMed ID: 9233280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does connection to primary care matter for children with attention-deficit/hyperactivity disorder?
    Toomey SL; Finkelstein J; Kuhlthau K
    Pediatrics; 2008 Aug; 122(2):368-74. PubMed ID: 18676555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.